Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shadia Zaman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|December 4, 2013
Targeting the apoptosis pathway in hematologic malignanciesShadia Zaman, Rui Wang, Varsha Gandhi
Experimental Hematology|August 11, 2015
Targeting executioner procaspase-3 with the procaspase-activating compound B-PAC-1 induces apoptosis in multiple myeloma cellsShadia Zaman, Rui Wang, Varsha Gandhi
Gene Regulation and Systems Biology|May 5, 2017
Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug ReactionsShadia Zaman, Sirarat Sarntivijai, Darrell R Abernethy
Molecular Biology of the Cell|August 19, 2007
Protein kinase A and Sch9 cooperatively regulate induction of autophagy in Saccharomyces cerevisiaeTomohiro Yorimitsu, Shadia Zaman, James R Broach, et al.
Annual Review of Genetics|February 29, 2008
How Saccharomyces responds to nutrientsShadia Zaman, Soyeon Im Lippman, Xin Zhao, et al.
Molecular Systems Biology|February 20, 2009
Glucose regulates transcription in yeast through a network of signaling pathwaysShadia Zaman, Soyeon I Lippman, Lisa Schneper, et al.
International Journal of Endocrinology|August 19, 2014
FBP1 Is an Interacting Partner of MeninShadia Zaman, Karen Sukhodolets, Patricia Wang, et al.
Neoplasia (New York, N.Y.)|March 27, 2015
Targeting the pro-survival protein MET with tivantinib (ARQ 197) inhibits growth of multiple myeloma cellsShadia Zaman, Shujun Shentu, Jing Yang, et al.
Cancer Research|December 4, 2010
The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localizationYan Wang, Atsushi Ozawa, Shadia Zaman, et al.
Drug Safety|March 23, 2016
Linking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase InhibitorsSirarat Sarntivijai, Shelley Zhang, Desikan G Jagannathan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|December 4, 2013
Targeting the apoptosis pathway in hematologic malignanciesShadia Zaman, Rui Wang, Varsha Gandhi
Experimental Hematology|August 11, 2015
Targeting executioner procaspase-3 with the procaspase-activating compound B-PAC-1 induces apoptosis in multiple myeloma cellsShadia Zaman, Rui Wang, Varsha Gandhi
Gene Regulation and Systems Biology|May 5, 2017
Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug ReactionsShadia Zaman, Sirarat Sarntivijai, Darrell R Abernethy
Molecular Biology of the Cell|August 19, 2007
Protein kinase A and Sch9 cooperatively regulate induction of autophagy in Saccharomyces cerevisiaeTomohiro Yorimitsu, Shadia Zaman, James R Broach, et al.
Annual Review of Genetics|February 29, 2008
How Saccharomyces responds to nutrientsShadia Zaman, Soyeon Im Lippman, Xin Zhao, et al.
Molecular Systems Biology|February 20, 2009
Glucose regulates transcription in yeast through a network of signaling pathwaysShadia Zaman, Soyeon I Lippman, Lisa Schneper, et al.
International Journal of Endocrinology|August 19, 2014
FBP1 Is an Interacting Partner of MeninShadia Zaman, Karen Sukhodolets, Patricia Wang, et al.
Neoplasia (New York, N.Y.)|March 27, 2015
Targeting the pro-survival protein MET with tivantinib (ARQ 197) inhibits growth of multiple myeloma cellsShadia Zaman, Shujun Shentu, Jing Yang, et al.
Cancer Research|December 4, 2010
The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localizationYan Wang, Atsushi Ozawa, Shadia Zaman, et al.
Drug Safety|March 23, 2016
Linking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase InhibitorsSirarat Sarntivijai, Shelley Zhang, Desikan G Jagannathan, et al.
Pageof 2